ANTIDIABETIC AGENT ENGLITAZONE ENHANCES INSULIN ACTION IN NONDIABETIC RATS WITHOUT PRODUCING HYPOGLYCEMIA

被引:39
作者
STEVENSON, RW
MCPHERSON, RK
GENEREUX, PE
DANBURY, BH
KREUTTER, DK
机构
[1] Department of Metabolic Diseases, Central Research Division, Pfizer Inc, Groton, CT
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1991年 / 40卷 / 12期
关键词
D O I
10.1016/0026-0495(91)90027-T
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The new antihyperglycemic agent englitazone (CP-68,722) was examined in nondiabetic rats. Administration of englitazone at 50 mg/kg/d for 8 days did not produce overt hypoglycemia but it lowered basal plasma insulin by 59% and 41% in rats fed ad libitum and fasted overnight on the last day, respectively. Drug treatment also lowered (P <.05) plasma nonesterified fatty acids (1.09 ± 0.05 to 0.36 ± 0.05 mmol/L) and cholesterol (2.41 ± 0.08 to 2.06 ± 0.07 mmol/L) in fasted rats, and glycerol (0.25 ± 0.02 to 0.14 ± 0.02 mmol/L) in fed rats but had no effect on 3-hydroxybutyrate or lactate levels despite the hypoinsulinemia. Disposition of an oral glucose load (1 g/kg) in drug-treated fed rats was identical to that in control rats despite a 40% reduction in the area under the plasma insulin curve. Insulin-stimulated 2-deoxy-D-3H-glucose uptake was significantly (P < .05) enhanced in adipocytes prepared from both fasted and fed drug-treated rats (0.56 ± 0.07 to 0.84 ± 0.03 and 0.79 ± 0.02 to 1.00 ± 0.02 nmol 5 min, respectively, at insulin concentration of 2,500 μU/mL). There was also a significant increase in the basal rate of 2-deoxyglucose uptake ( 0.07 ± 0.01 to 0.24 ± 0.07 nmol 5min) in adipocytes from fasted rats only. Insulin-stimulated lipogenesis from 3H-2-glucose was enhanced in adipocytes from drug-treated fed rats ( 7.72 ± 0.09 to 10.19 ± 0.10 nmol glucose 45 min at insulin concentration of 2,500 μU/mL) but no effect was observed in adipocytes from fasted rats ( 2.57 ± 0.30 to 2.33 ± 0.16 nmol glucose 45 min). Thus, englitazone (1) enhances insulin action in nondiabetic rats without producing overt hypoglycemia, (2) exhibits insulinomimetic activity with respect to hexose transport in adipocytes from drug-treated fasted rats, and (3) enhances insulin action in adipocytes from drug-treated fasted and fed rats, but (4) prevents the excess glucose entering the cells from fasted rats from being converted to triglyceride. © 1991.
引用
收藏
页码:1268 / 1274
页数:7
相关论文
共 20 条
[1]   INHIBITION OF GLUCOSE TRANSPORT IN HUMAN ERYTHROCYTE BY CYTOCHALASIN-B [J].
BLOCH, R .
BIOCHEMISTRY, 1973, 12 (23) :4799-4801
[2]   ASSAY FOR NANOGRAM QUANTITIES OF DNA IN CELLULAR HOMOGENATES [J].
BRUNK, CF ;
JONES, KC ;
JAMES, TW .
ANALYTICAL BIOCHEMISTRY, 1979, 92 (02) :497-500
[3]   CIGLITAZONE, A NEW HYPOGLYCEMIC AGENT .2. EFFECT ON GLUCOSE AND LIPID METABOLISMS AND INSULIN BINDING IN THE ADIPOSE-TISSUE OF C57BL/6J-OB/OB AND - + [J].
CHANG, AY ;
WYSE, BM ;
GILCHRIST, BJ .
DIABETES, 1983, 32 (09) :839-845
[4]   CIGLITAZONE, A NEW HYPOGLYCEMIC AGENT .1. STUDIES IN OB/OB AND DB/DB MICE, DIABETIC CHINESE HAMSTERS, AND NORMAL AND STREPTOZOTOCIN-DIABETIC RATS [J].
CHANG, AY ;
WYSE, BM ;
GILCHRIST, BJ ;
PETERSON, T ;
DIANI, AR .
DIABETES, 1983, 32 (09) :830-838
[5]  
CHANG AY, 1983, DIABETOLOGIA, V25, P514
[6]   SULFONYLUREAS AND HYPOGLYCEMIA [J].
FERNER, RE ;
NEIL, HAW .
BRITISH MEDICAL JOURNAL, 1988, 296 (6627) :949-950
[7]   REDUCTION OF INSULIN RESISTANCE IN OBESE AND OR DIABETIC ANIMALS BY 5-[4-(1-METHYLCYCLOHEXYLMETHOXY)BENZYL]-THIAZOLIDINE-2,4-DIONE (ADD-3878, U-63,287, CIGLITAZONE), A NEW ANTI-DIABETIC AGENT [J].
FUJITA, T ;
SUGIYAMA, Y ;
TAKETOMI, S ;
SOHDA, T ;
KAWAMATSU, Y ;
IWATSUKA, H ;
SUZUOKI, Z .
DIABETES, 1983, 32 (09) :804-810
[8]   CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].
FUJIWARA, T ;
YOSHIOKA, S ;
YOSHIOKA, T ;
USHIYAMA, I ;
HORIKOSHI, H .
DIABETES, 1988, 37 (11) :1549-1558
[9]  
GERICH JE, 1989, NEW ENGL J MED, V321, P1231
[10]  
GIBBS EM, 1989, DIABETOLOGIA, V32, pA491